Minerva Neurosciences (NERV) Current Assets (2013 - 2026)

Minerva Neurosciences has reported Current Assets for 14 years, with the latest figure at $79.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 341.32% year-over-year to $79.1 million; the trailing twelve-month figure through Mar 2026 stood at $79.1 million (up 341.32% YoY), and the FY2025 full-year result was $83.1 million, up 273.16% from the prior year.
• Current Assets for Q1 2026 stood at $79.1 million, down from $83.1 million in the prior quarter.
• The five-year high for Current Assets was $83.1 million in Q4 2025, with the low at $13.0 million in Q3 2025.
• Historically, Current Assets has averaged $40.9 million across 5 years, with a median of $40.2 million in 2022.
• Annual changes were most pronounced in 2025 — Current Assets slumped 53.39% — and 2026, when it jumped 341.32%.
• Minerva Neurosciences' Current Assets stood at $40.2 million in 2022, then gained by 4.59% to $42.0 million in 2023, then slumped by 46.98% to $22.3 million in 2024, then soared by 273.16% to $83.1 million in 2025, then slipped by 4.8% to $79.1 million in 2026.
• The last three Current Assets figures came in at $79.1 million (Q1 2026), $83.1 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.